Literature DB >> 7309236

Role of iron in the pathogenesis of Vibrio vulnificus infections.

A C Wright, L M Simpson, J D Oliver.   

Abstract

Infections with Vibrio vulnificus resulting in septicemia and high mortality have been correlated with pre-existing liver disease and hemochromatosis. As these conditions are associated with impaired iron metabolism and as iron availability in the host has been implicated in the pathogenicity of a number of bacterial infections, the role of iron as a possible factor in the pathogenesis of V. vulnificus was examined. Injection of mice with iron resulted in a lowering of the 50% lethal dose from 10(6) to 1.1 cells and in a reduction in the time of death postinfection. Elevated serum iron levels were also produced by damaging livers with injections of CCl4. The inoculum size required to kill these mice was directly correlated with serum iron levels. Since the portal of infection of this organism may be ingestion of contaminated seafood, the effects of iron upon orally induced infection were also studied. The effects of adding iron, transferrin, or Desferal (an iron chelate) upon the growth of V. vulnificus in human and rabbit sera were also examined. Iron appeared to be the limiting factor in the ability of this organism to survive or grow in mammalian sera. These results, both in vitro and in vivo, provided strong evidence that iron may play a major role in the pathogenesis of V. vulnificus.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7309236      PMCID: PMC350895          DOI: 10.1128/iai.34.2.503-507.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  16 in total

1.  The serum iron in experimental hepatocellular necrosis.

Authors:  K R REISSMAN; J BOLEY; J F CHRISTIANSON; M H DELP
Journal:  J Lab Clin Med       Date:  1954-04

2.  An Iron-binding Component in Human Blood Plasma.

Authors:  A L Schade; L Caroline
Journal:  Science       Date:  1946-10-11       Impact factor: 47.728

Review 3.  Iron and infection.

Authors:  E D Weinberg
Journal:  Microbiol Rev       Date:  1978-03

Review 4.  Iron and susceptibility to infectious disease.

Authors:  E D Weinberg
Journal:  Science       Date:  1974-05-31       Impact factor: 47.728

5.  Vibrio vulnificus (lactose-positive vibrio) and Vibrio parahaemolyticus differ in their susceptibilities to human serum.

Authors:  M M Carruthers; W J Kabat
Journal:  Infect Immun       Date:  1981-05       Impact factor: 3.441

6.  The effect of iron and transferrin on the killing of Escherichia coli in fresh serum.

Authors:  J Fletcher
Journal:  Immunology       Date:  1971-04       Impact factor: 7.397

7.  Neisseria meningitidis infection in mice: influence of iron, variations in virulence among strains, and pathology.

Authors:  B E Holbein; K W Jericho; G C Likes
Journal:  Infect Immun       Date:  1979-05       Impact factor: 3.441

8.  Mechanism of tuberculostasis in mammalian serum. II. Induction of serum tuberculostasis in guinea pigs.

Authors:  I Kochan; C A Golden; J A Bukovic
Journal:  J Bacteriol       Date:  1969-10       Impact factor: 3.490

9.  Effects of injected iron and siderophores on infections in normal and immune mice.

Authors:  I Kochan; J Wasynczuk; M A McCabe
Journal:  Infect Immun       Date:  1978-11       Impact factor: 3.441

10.  Iron-controlled infection with Neisseria meningitidis in mice.

Authors:  B E Holbein
Journal:  Infect Immun       Date:  1980-09       Impact factor: 3.441

View more
  113 in total

1.  Short day lengths attenuate the symptoms of infection in Siberian hamsters.

Authors:  Staci D Bilbo; Deborah L Drazen; Ning Quan; Lingli He; Randy J Nelson
Journal:  Proc Biol Sci       Date:  2002-03-07       Impact factor: 5.349

2.  VvpM, an extracellular metalloprotease of Vibrio vulnificus, induces apoptotic death of human cells.

Authors:  Mi-Ae Lee; Jeong-A Kim; Yu Jin Yang; Mee-Young Shin; Soon-Jung Park; Kyu-Ho Lee
Journal:  J Microbiol       Date:  2014-11-03       Impact factor: 3.422

Review 3.  Hepcidin: the missing link between hemochromatosis and infections.

Authors:  Houman Ashrafian
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

4.  Virulence characteristics of clinical and environmental isolates of Vibrio vulnificus.

Authors:  G N Stelma; A L Reyes; J T Peeler; C H Johnson; P L Spaulding
Journal:  Appl Environ Microbiol       Date:  1992-09       Impact factor: 4.792

5.  Role of flagellum and motility in pathogenesis of Vibrio vulnificus.

Authors:  Jong-Ho Lee; Jong Bok Rho; Kyung-Je Park; Chang Beom Kim; Yang-Soo Han; Sang Ho Choi; Kyu-Ho Lee; Soon-Jung Park
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

6.  Homodimerization and binding of specific domains to the target DNA are essential requirements for HlyU to regulate expression of the virulence gene rtxA1, encoding the repeat-in-toxin protein in the human pathogen Vibrio vulnificus.

Authors:  Moqing Liu; Michael Rose; Jorge H Crosa
Journal:  J Bacteriol       Date:  2011-10-21       Impact factor: 3.490

7.  The TonB3 system in the human pathogen Vibrio vulnificus is under the control of the global regulators Lrp and cyclic AMP receptor protein.

Authors:  Alejandro F Alice; Jorge H Crosa
Journal:  J Bacteriol       Date:  2012-02-03       Impact factor: 3.490

8.  Cloning and characterization of vuuA, a gene encoding the Vibrio vulnificus ferric vulnibactin receptor.

Authors:  A C Webster; C M Litwin
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

9.  Proteomics and 1H NMR-based metabolomics analysis of pathogenic Vibrio vulnificus aquacultures isolated from sewage drains.

Authors:  Chundan Zhang; Zhonghua Wang; Dijun Zhang; Jun Zhou; Chenyang Lu; Xiurong Su; Dewen Ding
Journal:  Environ Sci Pollut Res Int       Date:  2017-09-01       Impact factor: 4.223

10.  Proteus mirabilis amino acid deaminase: cloning, nucleotide sequence, and characterization of aad.

Authors:  G Massad; H Zhao; H L Mobley
Journal:  J Bacteriol       Date:  1995-10       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.